Trial Profile
The effectiveness of idazoxan in treating TRD [treatment-resistant depression]
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 14 Feb 2008
Price :
$35
*
At a glance
- Drugs Idazoxan (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 28 Jan 2008 Status changed from initiated to withdrawn prior to recruitment according to NCT.
- 14 Oct 2006 New trial record.